How to Develop and Implement a National Drug Policy (Second Edition)
(2001; 96 pages) [French] [Spanish] View the PDF document
Table of Contents
View the documentContributors
View the documentAbbreviations and acronyms
View the documentPreface
Open this folder and view contentsPart I: How to develop and implement a national drug policy
Close this folderPart II: Key components of a national drug policy
Open this folder and view contents4. Selection of essential drugs
Open this folder and view contents5. Affordability
Open this folder and view contents6. Drug financing
Open this folder and view contents7. Supply systems
Open this folder and view contents8. Drug regulation
Open this folder and view contents9. Rational use of drugs
Open this folder and view contents10. Research
Open this folder and view contents11. Human resources development
Close this folder12. Monitoring and evaluation
View the document12.1 Monitoring and evaluation are part of a national drug policy
View the documentReferences
View the documentSelected WHO publications and documents of related interest
View the documentBack cover
 

12. Monitoring and evaluation

Key policy issues

Monitoring and evaluation are an essential part of a national drug policy, and the necessary provisions need to be included in the policy. Key policy issues are:

• explicit government commitment to the principles of monitoring and evaluation;

• monitoring of the pharmaceutical sector through regular indicator-based surveys;

• independent external evaluation of the impact of the national drug policy on all sectors of the community and the economy.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: March 20, 2014